The Prognostic Model Established by the Differential Expression Genes Based on CD8+ T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma
Osteosarcoma (OS) is a malignant tumor with an extremely poor prognosis, especially in progressive patients. Immunotherapy based on immune checkpoint inhibitors (ICIs) is considered to be a promising treatment option for OS. Due to tumor heterogeneity, only a minority of patients benefit from immuno...
Main Authors: | Yu Chen, Wei Yan, Hongqing Wang, Zhiliang Ou, Huihong Chen, Zhenhua Huang, Jinlian Yang, Biqiong Liu, Fanjie Ou, Huang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2023-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2023/6563609 |
Similar Items
-
Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma
by: Yibo Ma, et al.
Published: (2023-01-01) -
Novel Immunotherapies for Osteosarcoma
by: Yubao Lu, et al.
Published: (2022-04-01) -
Integrating artificial intelligence in osteosarcoma prognosis: the prognostic significance of SERPINE2 and CPT1B biomarkers
by: Haishun Qu, et al.
Published: (2024-02-01) -
Immunotherapy for osteosarcoma
by: Kenichiro Yahiro, et al.
Published: (2021-05-01) -
Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
by: Yuan Zong, et al.
Published: (2023-06-01)